ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
Clinical trial NCT05501769 · COMPLETED
Trial details
- NCT number
- NCT05501769
- Sponsor
- Arvinas Estrogen Receptor, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-08
- Primary completion
- 2024-07-03
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.